allisartan isoproxil tablets
indications
for the treatment of mild and moderate essential hypertension.
declaration:
the detailed prescription information of this product should be subject to confirmation by the latest approved version of the state food and drug administration.
the product information on this website is not for pharmaceutical advertising, but presented as product knowledge for the reference of professionals in the pharmaceutical industry only. it must not be used for the diagnosis of diseases, and it cannot replace medical advice provided by doctors or other qualified medical professionals.
clopidogrel bisulfate tablets
indications
secondary prevention of atherosclerosis events in following patients:
patients with non-st-segment elevation acute coronary syndrome (unstable angina and non-st-elevation myocardial infarction), including patients undergoing a stent placement after percutaneous coronary intervention (pci). should be administered in conjunction with aspirin.
patients with acute st-elevation myocardial infarction. should be administered in conjunction with aspirin during thrombolytic therapy.
patients suffering from myocardial infarction (from a few days to less than 35 days), ischemic stroke (from 7 days to less than 6 months) or established peripheral arterial disease.
declaration:
the detailed prescription information of this product should be subject to confirmation by the latest approved version of the state food and drug administration.
the product information on this website is not for pharmaceutical advertising, but presented as product knowledge for the reference of professionals in the pharmaceutical industry only. it must not be used for the diagnosis of diseases, and it cannot replace medical advice provided by doctors or other qualified medical professionals.
bivalirudin for injection
indications
an anticoagulant in adult patients undergoing percutaneous coronary intervention (pci).
declaration:
the detailed prescription information of this product should be subject to confirmation by the latest approved version of the state food and drug administration.
the product information on this website is not for pharmaceutical advertising, but presented as product knowledge for the reference of professionals in the pharmaceutical industry only. it must not be used for the diagnosis of diseases, and it cannot replace medical advice provided by doctors or other qualified medical professionals.
pamidronate disodium for injection
indications
for ostealgia caused by hypercalcemia associated with malignancy and osteolytic bone metastases.
declaration:
the detailed prescription information of this product should be subject to confirmation by the latest approved version of the state food and drug administration.
the product information on this website is not for pharmaceutical advertising, but presented as product knowledge for the reference of professionals in the pharmaceutical industry only. it must not be used for the diagnosis of diseases, and it cannot replace medical advice provided by doctors or other qualified medical professionals.
desloratadine tablets
indications
for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis and chronic idiopathic urticaria.
declaration:
the detailed prescription information of this product should be subject to confirmation by the latest approved version of the state food and drug administration.
the product information on this website is not for pharmaceutical advertising, but presented as product knowledge for the reference of professionals in the pharmaceutical industry only. it must not be used for the diagnosis of diseases, and it cannot replace medical advice provided by doctors or other qualified medical professionals.
benazepril hydrochloride tablets
indications
for each period of hypertension
for congestive heart failure
adjuvant therapy for patients of congestive heart failure (nyha grade ⅱ-ⅳ) with limited reaction to digitalis or diuretics
declaration:
the detailed prescription information of this product should be subject to confirmation by the latest approved version of the state food and drug administration.
the product information on this website is not for pharmaceutical advertising, but presented as product knowledge for the reference of professionals in the pharmaceutical industry only. it must not be used for the diagnosis of diseases, and it cannot replace medical advice provided by doctors or other qualified medical professionals.
